- Home
- EPRX vs LICN Comparison
EPRX vs LICN Comparison
Compare EPRX & LICN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPRX
- LICN
- Stock Information
- Founded
- EPRX 2011
- LICN 2004
- Country
- EPRX Canada
- LICN China
- Employees
- EPRX N/A
- LICN N/A
- Industry
- EPRX
- LICN
- Sector
- EPRX
- LICN
- Exchange
- EPRX NYSE
- LICN Nasdaq
- Market Cap
- EPRX 85.5M
- LICN 83.8M
- IPO Year
- EPRX N/A
- LICN 2023
- Fundamental
- Price
- EPRX $3.13
- LICN $1.88
- Analyst Decision
- EPRX
- LICN
- Analyst Count
- EPRX 0
- LICN 0
- Target Price
- EPRX N/A
- LICN N/A
- AVG Volume (30 Days)
- EPRX 19.8K
- LICN 813.5K
- Earning Date
- EPRX 11-07-2024
- LICN 11-26-2024
- Dividend Yield
- EPRX N/A
- LICN N/A
- EPS Growth
- EPRX N/A
- LICN 36.90
- EPS
- EPRX N/A
- LICN 0.28
- Revenue
- EPRX N/A
- LICN $41,929,000.00
- Revenue This Year
- EPRX N/A
- LICN N/A
- Revenue Next Year
- EPRX N/A
- LICN N/A
- P/E Ratio
- EPRX N/A
- LICN $6.82
- Revenue Growth
- EPRX N/A
- LICN 24.86
- 52 Week Low
- EPRX $2.20
- LICN $0.50
- 52 Week High
- EPRX $3.79
- LICN $2.44
- Technical
- Relative Strength Index (RSI)
- EPRX N/A
- LICN 47.29
- Support Level
- EPRX N/A
- LICN $1.96
- Resistance Level
- EPRX N/A
- LICN $2.31
- Average True Range (ATR)
- EPRX 0.00
- LICN 0.20
- MACD
- EPRX 0.00
- LICN -0.02
- Stochastic Oscillator
- EPRX 0.00
- LICN 29.51
About EPRX EUPRAXIA PHARMACEUTICALS INC
Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product EP-104 is used for the treatment of osteoarthritis and eosinophilic esophagitis symptoms. The company leverages its proprietary Diffusphere technology to optimize drug delivery for applications with significant unmet medical needs.
About LICN Lichen China Limited
Lichen China Ltd is a holding company. The company, along with its subsidiaries provides financial and taxation solution services; education support services; and software and maintenance services. The company generates Majority revenue from Financial and taxation solution services.